Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Department of Family Medicine, University of California San Diego, San Diego, CA, USA.
Atherosclerosis. 2021 Dec;338:15-22. doi: 10.1016/j.atherosclerosis.2021.11.002. Epub 2021 Nov 5.
Extra-coronary calcification (ECC) is a marker of atherosclerosis and independently associated with cardiovascular disease (CVD). Adipokines may mediate the effect of obesity on atherosclerosis. However, the relationship of adipokines with ECC is not well-established. We examined the associations of leptin, resistin and adiponectin with ECC in a diverse community-based cohort.
We performed a cross-sectional analysis of 1897 adults without clinical CVD in the MESA cohort. Serum adipokine levels and non-contrast cardiac CT scans were obtained at Exam 2 or 3 (randomly assigned). ECC was quantified by Agatston score and included calcification of the mitral annulus (MAC), aortic valve (AVC), ascending thoracic aorta (ATAC) and descending thoracic aorta (DTAC). We used multivariable regression to evaluate the associations between leptin, resistin and adiponectin [per 1 SD ln(adipokine] with ECC prevalence (score >0) and extent [ln(score+1)].
The mean age of participants was 65 ± 10 years; 49% women. After adjusting for demographic factors, adiponectin was inversely associated with AVC prevalence and extent; leptin positively associated with MAC prevalence and extent; and resistin positively associated with ATAC prevalence and extent and DTAC extent. After adjustment for BMI and other CVD risk factors, adiponectin remained inversely associated with AVC prevalence, and resistin remained associated with greater ATAC prevalence and extent. Leptin was not associated with measures of ECC after full adjustment. No adipokine was associated with MAC after full adjustment.
We identified significant associations between select adipokines and specific markers of ECC. Adipokines may play a role in the development of systemic atherosclerosis.
冠状动脉外钙化(ECC)是动脉粥样硬化的标志物,与心血管疾病(CVD)独立相关。脂肪因子可能介导肥胖对动脉粥样硬化的影响。然而,脂肪因子与 ECC 的关系尚未得到充分确立。我们在一个多样化的社区队列中检查了瘦素、抵抗素和脂联素与 ECC 的关系。
我们对 MESA 队列中 1897 名无临床 CVD 的成年人进行了横断面分析。在检查 2 或 3 时获得了血清脂肪因子水平和非对比性心脏 CT 扫描(随机分配)。ECC 通过 Agatston 评分进行量化,包括二尖瓣环(MAC)、主动脉瓣(AVC)、升主动脉(ATAC)和降主动脉(DTAC)的钙化。我们使用多变量回归来评估瘦素、抵抗素和脂联素[每 1 SD ln(脂肪因子)]与 ECC 患病率(评分>0)和程度[ln(评分+1)]之间的关系。
参与者的平均年龄为 65±10 岁;49%为女性。在调整人口统计学因素后,脂联素与 AVC 患病率和程度呈负相关;瘦素与 MAC 患病率和程度呈正相关;抵抗素与 ATAC 患病率和程度以及 DTAC 程度呈正相关。在调整 BMI 和其他 CVD 危险因素后,脂联素与 AVC 患病率仍呈负相关,抵抗素与 ATAC 患病率和程度仍呈正相关。在充分调整后,瘦素与 ECC 无显著相关。在充分调整后,没有脂肪因子与 MAC 相关。
我们发现了一些特定脂肪因子与 ECC 特定标志物之间的显著相关性。脂肪因子可能在全身动脉粥样硬化的发展中发挥作用。